Literature DB >> 21751347

High-sensitivity TFA-free LC-MS for profiling histones.

Jia You1, Liwen Wang, Motoyasu Saji, Susan V Olesik, Matthew D Ringel, David M Lucas, John C Byrd, Michael A Freitas.   

Abstract

The analysis of proteins by RPLC commonly involves the use of TFA as an ion-pairing agent, even though it forms adducts and suppresses sensitivity. The presence of adducts can complicate protein molecular weight assignment especially when protein isoforms coelute as in the case of histones. To mitigate the complicating effects of TFA adducts in protein LC-MS, we have optimized TFA-free methods for protein separation. Protein standards and histones were used to evaluate TFA-free separations using capillary (0.3 mm id) and nanoscale (0.1 mm id) C(8) columns with the ion-pairing agents, formic acid or acetic acid. The optimized method was then used to examine the applicability of the approach for histone characterization in human cancer cell lines and primary tumor cells from chronic lymphocytic leukemia patients.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21751347      PMCID: PMC3517135          DOI: 10.1002/pmic.201000445

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  34 in total

1.  Tup1-Ssn6 interacts with multiple class I histone deacetylases in vivo.

Authors:  Judith K Davie; Diane G Edmondson; Cherie B Coco; Sharon Y R Dent
Journal:  J Biol Chem       Date:  2003-10-02       Impact factor: 5.157

2.  Trans-tail histone modifications: wedge or bridge?

Authors:  Karl W Henry; Shelley L Berger
Journal:  Nat Struct Biol       Date:  2002-08

3.  Liquid chromatography mass spectrometry profiling of histones.

Authors:  Xiaodan Su; Naduparambil K Jacob; Ravindra Amunugama; David M Lucas; Amy R Knapp; Chen Ren; Melanie E Davis; Guido Marcucci; Mark R Parthun; John C Byrd; Richard Fishel; Michael A Freitas
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-01-07       Impact factor: 3.205

4.  Peptide mass mapping of acetylated isoforms of histone H4 from mouse lymphosarcoma cells treated with histone deacetylase (HDACs) inhibitors.

Authors:  Chen Ren; Liwen Zhang; Michael A Freitas; Kalpana Ghoshal; Mark R Parthun; Samson T Jacob
Journal:  J Am Soc Mass Spectrom       Date:  2005-10       Impact factor: 3.109

Review 5.  The effect of the mobile phase additives on sensitivity in the analysis of peptides and proteins by high-performance liquid chromatography-electrospray mass spectrometry.

Authors:  M C García
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-04-26       Impact factor: 3.205

6.  Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer.

Authors:  Mario F Fraga; Esteban Ballestar; Ana Villar-Garea; Manuel Boix-Chornet; Jesus Espada; Gunnar Schotta; Tiziana Bonaldi; Claire Haydon; Santiago Ropero; Kevin Petrie; N Gopalakrishna Iyer; Alberto Pérez-Rosado; Enrique Calvo; Juan A Lopez; Amparo Cano; Maria J Calasanz; Dolors Colomer; Miguel Angel Piris; Natalie Ahn; Axel Imhof; Carlos Caldas; Thomas Jenuwein; Manel Esteller
Journal:  Nat Genet       Date:  2005-03-13       Impact factor: 38.330

7.  Characterization of histone H2A and H2B variants and their post-translational modifications by mass spectrometry.

Authors:  Débora Bonenfant; Michèle Coulot; Harry Towbin; Patrick Schindler; Jan van Oostrum
Journal:  Mol Cell Proteomics       Date:  2005-11-30       Impact factor: 5.911

8.  Enrichment and characterization of histones by two-dimensional hydroxyapatite/reversed-phase liquid chromatography-mass spectrometry.

Authors:  Xiaodan Su; Naduparambil K Jacob; Ravindra Amunugama; Pang-Hung Hsu; Richard Fishel; Michael A Freitas
Journal:  Anal Biochem       Date:  2009-02-03       Impact factor: 3.365

9.  Enhanced sensitivity for peptide mapping with electrospray liquid chromatography-mass spectrometry in the presence of signal suppression due to trifluoroacetic acid-containing mobile phases.

Authors:  A Apffel; S Fischer; G Goldberg; P C Goodley; F E Kuhlmann
Journal:  J Chromatogr A       Date:  1995-09-29       Impact factor: 4.759

10.  Global turnover of histone post-translational modifications and variants in human cells.

Authors:  Barry M Zee; Rebecca S Levin; Peter A DiMaggio; Benjamin A Garcia
Journal:  Epigenetics Chromatin       Date:  2010-12-06       Impact factor: 4.954

View more
  5 in total

1.  Chromatographic efficiency and selectivity in top-down proteomics of histones.

Authors:  Yiyang Zhou; Ximo Zhang; Luca Fornelli; Philip D Compton; Neil Kelleher; Mary J Wirth
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-12-23       Impact factor: 3.205

Review 2.  Proteomic challenges: sample preparation techniques for microgram-quantity protein analysis from biological samples.

Authors:  Peter Feist; Amanda B Hummon
Journal:  Int J Mol Sci       Date:  2015-02-05       Impact factor: 5.923

3.  Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory Adults.

Authors:  Samantha R Renusch; Sean Harshman; Hongyang Pi; Eileen Workman; Allison Wehr; Xiaobai Li; Thomas W Prior; Bakri H Elsheikh; Kathryn J Swoboda; Louise R Simard; John T Kissel; Daniel Battle; Mark R Parthun; Michael A Freitas; Stephen J Kolb
Journal:  J Neuromuscul Dis       Date:  2015-06-04

4.  Hypoxia and hypoxia mimetics differentially modulate histone post-translational modifications.

Authors:  Kuo-Feng Hsu; Sarah E Wilkins; Richard J Hopkinson; Rok Sekirnik; Emily Flashman; Akane Kawamura; James S O McCullagh; Louise J Walport; Christopher J Schofield
Journal:  Epigenetics       Date:  2020-07-01       Impact factor: 4.528

5.  Proteomic profiling identifies specific histone species associated with leukemic and cancer cells.

Authors:  Rajbir Singh; Sean W Harshman; Amy S Ruppert; Amir Mortazavi; David M Lucas; Jennifer M Thomas-Ahner; Steven K Clinton; John C Byrd; Michael A Freitas; Mark R Parthun
Journal:  Clin Proteomics       Date:  2015-08-27       Impact factor: 3.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.